COMPAGNIE CHARGEURS INVEST (CRI.PA) Fundamental Analysis & Valuation
EPA:CRI • FR0000130692
Current stock price
8.885 EUR
-0.02 (-0.17%)
Last:
This CRI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CRI.PA Profitability Analysis
1.1 Basic Checks
- In the past year CRI was profitable.
- CRI had a positive operating cash flow in the past year.
- Of the past 5 years CRI 4 years were profitable.
- The reported operating cash flow has been mixed in the past 5 years: CRI reported negative operating cash flow in multiple years.
1.2 Ratios
- With a Return On Assets value of 0.28%, CRI is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
- CRI has a worse Return On Equity (1.03%) than 70.59% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 5.14%, CRI is in line with its industry, outperforming 58.82% of the companies in the same industry.
- CRI had an Average Return On Invested Capital over the past 3 years of 4.65%. This is below the industry average of 7.06%.
- The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.14%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROIC | 5.14% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
- CRI's Profit Margin of 0.37% is on the low side compared to the rest of the industry. CRI is outperformed by 70.59% of its industry peers.
- CRI's Profit Margin has declined in the last couple of years.
- CRI has a Operating Margin of 6.41%. This is in the lower half of the industry: CRI underperforms 64.71% of its industry peers.
- CRI's Operating Margin has been stable in the last couple of years.
- The Gross Margin of CRI (28.51%) is worse than 76.47% of its industry peers.
- In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. CRI.PA Health Analysis
2.1 Basic Checks
- CRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, CRI has more shares outstanding
- Compared to 5 years ago, CRI has more shares outstanding
- The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.21, we must say that CRI is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of 1.21, CRI is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
- CRI has a debt to FCF ratio of 124.09. This is a negative value and a sign of low solvency as CRI would need 124.09 years to pay back of all of its debts.
- CRI's Debt to FCF ratio of 124.09 is on the low side compared to the rest of the industry. CRI is outperformed by 64.71% of its industry peers.
- CRI has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 1.38, CRI is in line with its industry, outperforming 41.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Altman-Z | 1.21 |
ROIC/WACC0.81
WACC6.35%
2.3 Liquidity
- A Current Ratio of 1.30 indicates that CRI should not have too much problems paying its short term obligations.
- The Current ratio of CRI (1.30) is worse than 88.24% of its industry peers.
- A Quick Ratio of 0.86 indicates that CRI may have some problems paying its short term obligations.
- With a Quick ratio value of 0.86, CRI is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. CRI.PA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 150.24% over the past year.
- The earnings per share for CRI have been decreasing by -14.59% on average. This is quite bad
- CRI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.67%.
- The Revenue has been growing slightly by 3.10% on average over the past years.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
- CRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.91% yearly.
- The Revenue is expected to grow by 3.28% on average over the next years.
EPS Next Y-30.25%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue Next Year-1.02%
Revenue Next 2Y2.35%
Revenue Next 3Y3.28%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. CRI.PA Valuation Analysis
4.1 Price/Earnings Ratio
- CRI is valuated quite expensively with a Price/Earnings ratio of 68.35.
- Compared to the rest of the industry, the Price/Earnings ratio of CRI indicates a slightly more expensive valuation: CRI is more expensive than 70.59% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 25.23, CRI is valued quite expensively.
- With a Price/Forward Earnings ratio of 11.07, the valuation of CRI can be described as very reasonable.
- 76.47% of the companies in the same industry are more expensive than CRI, based on the Price/Forward Earnings ratio.
- CRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.35 | ||
| Fwd PE | 11.07 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CRI is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, CRI is valued a bit more expensive than the industry average as 64.71% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 65.04 | ||
| EV/EBITDA | 6.92 |
4.3 Compensation for Growth
- CRI's earnings are expected to grow with 33.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.84%
EPS Next 3Y33.91%
5. CRI.PA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.33%, CRI has a reasonable but not impressive dividend return.
- CRI's Dividend Yield is slightly below the industry average, which is at 3.00.
- Compared to the average S&P500 Dividend Yield of 1.91, CRI is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.33% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 118.52% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
CRI.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:CRI (3/20/2026, 2:37:37 PM)
8.885
-0.02 (-0.17%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)11-05 2025-11-05
Earnings (Next)03-19 2026-03-19/amc
Inst Owners4.62%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap221.15M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts74.29
Price Target12.41 (39.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.33% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.39%
PT rev (3m)7.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)15.09%
EPS NY rev (3m)-35.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.33%
Revenue NY rev (3m)-3.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.35 | ||
| Fwd PE | 11.07 | ||
| P/S | 0.3 | ||
| P/FCF | 65.04 | ||
| P/OCF | 9.29 | ||
| P/B | 0.85 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.92 |
EPS(TTM)0.13
EY1.46%
EPS(NY)0.8
Fwd EY9.04%
FCF(TTM)0.14
FCFY1.54%
OCF(TTM)0.96
OCFY10.76%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROCE | 7.02% | ||
| ROIC | 5.14% | ||
| ROICexc | 6.13% | ||
| ROICexgc | 13.12% | ||
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% | ||
| FCFM | 0.47% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Debt/EBITDA | 4.67 | ||
| Cap/Depr | 66.89% | ||
| Cap/Sales | 2.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.87% | ||
| Profit Quality | 125.93% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.21 |
F-Score7
WACC6.35%
ROIC/WACC0.81
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y-30.25%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year-1.02%
Revenue Next 2Y2.35%
Revenue Next 3Y3.28%
Revenue Next 5YN/A
EBIT growth 1Y57.43%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year102.09%
EBIT Next 3Y37.85%
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y244.24%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%
COMPAGNIE CHARGEURS INVEST / CRI.PA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for CRI stock?
The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 68.35 and the Price/Book (PB) ratio is 0.85.
How financially healthy is COMPAGNIE CHARGEURS INVEST?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.